UW Bioengineering faculty James Lai, Suzie Pun and Patrick Stayton, and BioE Ph.D. alumnus and affiliate faculty member Patrick Hsieh, are among contributing authors of a paper describing a novel treatment for limb ischemia.
BioE's Professor Emeritus Allan Hoffman, and adjunct faculty David Baker and Miqin Zhang are among 29 UW researchers to be included on 2016's "Highly Cited Researchers" report by Clarivate Analytics.
AVS (American Vacuum Society) is an international community of scientists, engineers and instrument manufacturers which strives to promote research and communicate knowledge in the important areas of surface, interface, vacuum and thin film science/technology for the advancement of humankind.
Research Associate Professor Eric Chudler traveled to Sherbaling Monastery, near Bir, India to teach Tibetan Buddhist monks about neuroscience. Each year since 2011, Dr. Chudler has made the journey to visit the Tibetan monastic community through the Science for Monks program.
UW Bioengineering announces three new assistant professors in neuroengineering (Andre Brendt, Azadeh Yazdan-Shahmorad joint with Electrical Engineering, and Amy Orsborn joint with Electrical Engineering) and one assistant professor in immunoenginering (Hao Yuan Kueh).
Dr. Kelly Stevens, an assistant professor in UW Bioengineering and in Pathology, has received a 2016 National institutes of Health (NIH) Director’s New Innovator Award in support of her work to build artificial human tissues from stem cells, and to remotely control these tissues after implantation in a patient.
The CDI hopes to improve the health and well-being of people with advanced kidney disease. Its. vision is that future dialysis therapy will be complication-free and completely restorative of kidney health.
College of Engineering features Bioengineers without Borders team’s project to create portable anesthesia device for developing countries
Photo: Eric Swanson and David Peeler, Bioengineers Without Borders team members and Bioengineering graduate students. A [...]
The researchers were selected for their proposal and business plan to develop a targeted drug delivery system for breast cancer which targets a specific population of tumor-promoting cells.
This award recognizes Dr. Stevens' efforts to address the clinical challenge of liver disease by building an artificial engineered liver using pluriopotent stem cells.